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Fiber typeCarnitine is well recognized as a key regulator of long-chain fatty acyl group translocation into themitochondria.
In addition, carnitine, as acetylcarnitine, acts as an acceptor of excess acetyl-CoA, a potent inhibitor of pyruvate
dehydrogenase. Here, we provide a new methodology for accurate quantiﬁcation of acetylcarnitine content
and determination of its localization in skeletal muscles. We used matrix-assisted laser desorption/ionization
imaging mass spectrometry (MALDI–IMS) to visualize acetylcarnitine distribution in rat skeletal muscles.
MALDI–IMS and immunohistochemistry of serial cross-sections showed that acetylcarnitine was enriched
in the slow-type muscle ﬁbers. The concentration of ATP was lower in muscle regions with abundant
acetylcarnitine, suggesting a relationship between acetylcarnitine and metabolic activity. Using our novel meth-
od, we detected an increase in acetylcarnitine content after muscle contraction. Importantly, this increase was
not detected using traditional biochemical assays of homogenized muscles. We also demonstrated that acetyla-
tion of carnitine during muscle contraction was concomitant with glycogen depletion. Our methodology would
be useful for the quantiﬁcation of acetylcarnitine and its contraction-induced kinetics in skeletal muscles.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Carnitine is a key factor in muscle cell metabolism, because it serves
as a carrier for energy substrates through mitochondrial membranes.
Carnitine is responsible for the translocation of long-chain acyl-CoAs de-
rived from circulating lipids into the mitochondrial matrix where they
enter the beta-oxidation pathway [1]. Long-chain acyl-CoAs are con-
verted to acylcarnitines by carnitine palmitoyltransferase 1, which is lo-
cated at the outer mitochondrial membrane [2]. Acylcarnitine can berption/ionization imaging mass
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fujiin@tmu.ac.jp (N.L. Fujii).transported via carnitine translocase, which re-converts acylcarnitine
back to carnitine and long-chain acyl-CoAs, which can then be oxidized.
Another major role of carnitine in skeletal muscles is to buffer excess
carbon fuels. In cases where beta-oxidation outpaces metabolic ﬂux
through the tricarboxylic acid (TCA) cycle, short-chain acyl-CoA inter-
mediates are accumulated in muscle mitochondria [3]. This situation is
reversed by carnitine acetyl-transferase (CrAT), which resides princi-
pally within the mitochondrial matrix where it acts selectively on
short chain acyl-CoAs. CrAT converts the accumulating short chain
(mainly C2–C10) acyl-CoA to acylcarnitine, which then exit the organ-
elle and the tissue [4].
Acylcarnitinehas been identiﬁed as ametabolic indicator, and serum
andmuscle acylcarnitine levels are known to reﬂect themetabolic state
[5]. More speciﬁcally, the shortest acylcarnitine (acetylcarnitine, C2) is
thought to be important for controlling metabolic ﬂexibility because
acetyl-CoA acts as a potent allosteric inhibitor of pyruvate dehydroge-
nase, a rate-limiting enzyme for pyruvate entry into the TCA cycle [6].
Additionally, over-accumulation of acetyl-CoA in muscle-speciﬁc
CrAT-deﬁcient mice was observed in the mitochondria and the mice
showed glucose intolerance and insulin resistance [4]. These ﬁndings
suggest that acetylation of carnitine is a key factor of muscle metabolic
ﬂexibility.
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creased in situations of enhanced fatty acid oxidation induced by
lipid infusion [7,8]. Additionally, high-intensity exercise increases
acetylcarnitine accumulation resulting from increased pyruvate dehy-
drogenase activity following enhanced glycolysis [9]. In these situations,
total carnitine content (sum of free-, acetyl-, and acyl-carnitine) does
not change [9], indicating that carnitine is converted to acetylcarnitine
in muscle cells. Changes in carnitine and acetylcarnitine contents have
been generally evaluated by enzymatic assay on the basis of the mea-
surement of CrAT activity [10,11]. A critical limitation of this assay is
that acetylcarnitine cannot be distinguished from other acylcarnitines
because CrAT has afﬁnity for varying the length of acyl-CoA ranging
from C2 (acetyl-CoA) to C10 [12]. For precise evaluation of
acetylcarnitine levels, liquid chromatography electrospray ioniza-
tion mass spectrometry has been used [11]. Previous studies have
comprehensively evaluated tissue carnitine species and distinguished
acetylcarnitine from the other acylcarnitines using this method [13].
However, using this method entails extraction and puriﬁcation steps,
which lead to loss of information on carnitine-distribution in biological
tissue.
In skeletalmuscles, carnitinemetabolism is presumed to be associat-
ed with muscle characteristics. Skeletal muscle is composed of hetero-
geneous ﬁber types, which are mainly distinguished into type I ﬁbers
(slow and oxidative) or type II ﬁbers (fast and glycolytic). We have pre-
viously demonstrated that carnitine uptake capacity and its transporter
OCTN2 (carnitine/organic cation transporter) expressionwere higher in
oxidative muscles than in glycolytic muscles, suggesting that carnitine
metabolism is higher in type I ﬁbers in which mitochondria are
abundant [14]. However, it remains unknown whether carnitine con-
tent and carnitine acetylation depend on ﬁber type-speciﬁc characteris-
tics because no method shows the localization of carnitine molecule in
tissues precisely.
Here, we used matrix-assisted laser desorption/ionization imaging
mass spectrometry (MALDI–IMS), which integrates microscopy and
mass spectrometry, for label-free, ex vivo visualization of acetylcarnitine
localization. This technique enables the discrimination of acetylcarnitine
from other species of acylcarnitine by determining the differences in
mass-to-charge ratios (m/z). The purpose of this study was to determine
the localization of acetylcarnitine in rat skeletal muscles and evaluate
changes in carnitine dynamics induced by muscle contraction using
MALDI–IMS. Our results showed that distribution of acetylcarnitine
was primarily in the slow-type ﬁbers, where high metabolic activity
was detected based on ATP concentration. We also demonstrated that
muscle contraction increased acetylcarnitine in a speciﬁc part ofmuscles,
which is concomitant with glycogen depletion.
2. Materials and methods
2.1. Materials
Thematrices, 2,5-dihydroxybenzoic acid (DHB), and 9-aminoacridine
(9-AA), were purchased from Bruker Daltonics (Bremen, Germany) and
Merck Schuchardt (Hohenbrunn, Germany), respectively. Methanol,
ethanol, and ultra-pure water (Wako Pure Chemical Industries, Osaka,
Japan) were used for the preparation of all buffers and solvents. All
chemicals used in this study were of the highest purity available. The
monoclonal antibodies used in this study were purchased from Sigma
(St. Louis, MO) and DSHB (Iowa City, IA).
2.2. Animals and in situ contraction
Care and use of laboratory animals were in accordance with the
Experimental Animal Committee of Tokyo Metropolitan University
and we followed the Guidelines for the Proper Conduct of Animal
Experiments established by the Science Council of Japan.In situ contractions were performed as previously described
[15] with some modiﬁcations. Brieﬂy, male Wistar rats weighing
250–300 g were anesthetized with sodium pentobarbital (50mg kg−1
intraperitoneally). Approximately 3 h prior to the experiment, the chow
was removed from the cages in order to eliminate the inﬂuence of feed-
ing. After the lower legs were shaved and cleaned, a surfaced electrode
(Vitrode, Nihon Kohden, Tokyo, Japan) was attached to the proximal
and distal regions of the calf muscle. Under resting conditions, the
right and left ankles and knee joints were ﬁxed at 90°. Isometric, te-
tanic muscle contractions were elicited in the left leg by
electrostimulation via a surface electrode with trains of stimuli
(0.2-ms pulse duration at 40 Hz, 10 V, lasting for 0.2 s). The calf muscles
(lateral and medial gastrocnemius and soleus) were stimulated. The
stimulation was applied at a rate of one contraction per second for
5 min or 30 min. The contralateral leg was considered as the resting
leg. Following contraction, muscle tissues were immediately dissected
and frozen in 2-methylbuthane and stored at−80 °C without ﬁxation.2.3. Measurement of muscle carnitine and glycogen content
For measurement of carnitine content, rat gastrocnemius muscle
was separated into its surface and deep portions. The deep portion of
gastrocnemius muscle, which is enriched with myoglobin, was identi-
ﬁed visually by its red tissue color; the surface portion was white in
color. Surface and deep portions are characterized as glycolytic and ox-
idativemuscles, respectively [16]. The isolatedmuscles wereminced on
ice, homogenized in 3% perchloric acid and centrifuged at 1000 ×g for
10 min. The supernatant was neutralized with 2.5 M K2CO3 and centri-
fuged at 1000 ×g. Total and free carnitine contents were determined by
the enzymatic cycling method (total and free carnitine assay kits,
Kainos). The acylcarnitine content was calculated from the difference
between total acid soluble and free carnitine [17].
For glycogenmeasurements, 10mg ofmuscle tissuewas hydrolyzed
in 2 M HCl and neutralized by adding 2 M NaOH, and then the
supernatant was used for glucose analysis. Glucose levels were deter-
mined using a hexokinase-dependent assay kit according to the
manufacturer's instructions (GAHK-20, Sigma).2.4. Histochemical analysis
Sectionswere prepared as described previously [18]. Brieﬂy, consec-
utive 10-μm sections were cut using a cryostat (CM 1850; Leica
Microsystems, Wetzlar, Germany). The serial sections were mounted
onto Matsunami Adhesive Slide-(MAS) coated slides (Matsunami,
Osaka, Japan) for histochemical staining, and indium-tin oxide-coated
glass slides (Bruker Daltonics) for imaging mass spectrometry. For
morphological observation, sections were stained with hematoxylin
and eosin (H&E). To evaluate glycogen content, the serial sections
were stained with periodic acid-Schiff stain (PAS, Millipore).2.5. Immunohistochemical analysis
For the determination of muscle-ﬁber type, sections were stained
with antibodies against myosin heavy chains. Tissue sections were
ﬁxed in 4% paraformaldehyde/phosphate buffer and incubatedwith pri-
mary antibodies against myosin heavy chain (MHC) type I (M8421,
Sigma), MHC II (M4276, Sigma), and MHC I + IIa (BF-32, DSHB) and
then visualized using appropriate species-speciﬁc Alexa Fluor 488
ﬂuorescence-conjugated secondary antibodies (Invitrogen). The ﬂuo-
rescence was detected with a wide ﬁeld ﬂuorescence microscope
(Keyence, Osaka, Japan). To classify the ﬁber types, the images of MHC
expression visualized using immunohistochemistry were converted to
black-and-white using ImageJ software (NIH, Bethesda, MD).
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Fig. 1. Comparison of muscle carnitine and the sum of acyl and acetylcarnitine content in
the surface and deep portions of rat gastrocnemius muscle, measured by enzymatic
analysis. Values are presented as mean ± SEM from 3 animals. *: p b 0.05 vs. surface
portion of muscle.
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Before imaging analysis was performed, tissue sections were cov-
ered with matrices. We detected carnitine species in positive-ion
mode where the molecules are detected as either the radical cations
or the protonated molecules. On the other hand, we measured nucleo-
tides in a negative-ion mode – where sample molecules are converted
to radical anions through absorption of electrons [19] – because a previ-
ous report showed that these metabolites were sensitively detected in
this mode [20]. For MALDI–MS in positive-ion mode, 50 mg/mL of
DHB in methanol/water (7/3, v/v) was sprayed uniformly over the sec-
tionswith a 0.2-mmnozzle caliber airbrush (Procon Boy FWAPlatinum;
Mr. Hobby, Tokyo, Japan). For MALDI–MS in negative-ion mode, 9-AA
was prepared at a concentration of 10 mg/mL in ethanol/water
(7/3, v/v) and used as a matrix. Imaging analysis was performed using
a MALDI-time-of-ﬂight/time-of-ﬂight (MALDI–TOF/TOF) instrument,
the Ultraﬂex II (Bruker Daltonics), as described previously [18] with
minor modiﬁcations. The instrument was equipped with a 355-nm
neodymium-doped yttrium aluminum garnet (Nd/YAG) laser with a
repetition rate of 200 Hz. The laser irradiated the tissue sections 200
times per position. All pixels were 200 μm. The mass spectrometry
parameters were set to obtain the highest sensitivity with m/z values
in the range of 40–600 in positive-ion mode and 200–1000 in
negative-ion mode. FlexImaging software (Bruker Daltonics) was used
for automatic acquisition of the spectra, reconstruction of the ion
images, and for total ion current normalization.
2.7. Tandem mass spectrometry
For the tandemmass spectrometric analysis (MS/MS), a QSTAR Elite
high-performance, hybrid quadrupole TOFmass spectrometer (Applied
Biosystems, Foster City, CA) was used according to a previously de-
scribed procedure [21]. The MS/MS analysis was performed directly
on tissue sections of the skeletal muscle. Collisional activation of select-
ed ions was carried out using relative collision energy with argon as the
collision gas. The conditions for data acquisition (laser power and colli-
sion energy) were changed in order to obtain product-ion mass spectra
with peaks that had high intensity and a high signal-to-noise ratio [21].
2.8. Data analysis
Energy chargewas assigned as ([ATP]+0.5 [ADP])/([ATP]+ [ADP]+
[AMP]) [22], and calculated using SIMenergy software (Shimadzu co.,
Kyoto, Japan) that is currently under development. All data are
expressed as mean ± standard error of the mean (SEM). Paired t-test
was used to compare the basal and contracted muscles. Variables
among ﬁber types were compared using one-way analysis of variance
(ANOVA). Tukey–Kramer post hoc test was conducted if the ANOVA
indicated a signiﬁcant difference. The level of signiﬁcance was set at
p b 0.05.
3. Results
3.1. Muscle carnitine content
We measured free carnitine and acyl + acetyl carnitine contents
based on enzymatic cycling in the surface and deep portions of gastroc-
nemiusmuscle in the resting rat legs. Although there was no signiﬁcant
difference in free carnitine content between the surface and deep
portions, acylcarnitine content was higher in the deep portion when
compared to the surface portion of gastrocnemius muscle (Fig. 1),
which is in accordance with previous reports [14]. However, this meth-
odwas not able to determinewhich acylcarnitineswere accumulated in
the deep portion of gastrocnemius muscle. Therefore, we next tried to
measure the precise acetylcarnitine content, without the contamination
of other short chain acylcarnitines, using mass spectrometry.3.2. MALDI–IMS carnitine imaging
To quantify carnitine and visualize its distribution directly, we per-
formed MALDI–IMS analyses using sections of gastrocnemius muscles.
Fig. 2a represents the distributions of protonated [M+H]+ ions derived
from carnitine atm/z 162.2 and acetylcarnitine atm/z 204.2. It was ob-
served that carnitine was distributed throughout the entire gastrocne-
mius muscle, while acetylcarnitine was localized in a speciﬁc region of
gastrocnemius muscle. To identify these molecules, we used a MS/MS.
The fragmentation spectra of these carnitine species were detected by
MALDI–MS/MS directly from the gastrocnemius muscle sections
(Fig. 2b). We conﬁrmed that carnitine is fragmented to a main product
ion at m/z 103, resulting from the loss of the trimethyl amine group.
Similar to previous reports [23], we also monitored the twomain prod-
uct ions atm/z 145 and 85 from acetylcarnitine by performing MS/MS.
Since acetylcarnitinewas detected in a speciﬁc region of gastrocnemi-
us muscle, we investigated the correlative distribution between muscle
ﬁber type and acetylcarnitine in serial sections through immunohisto-
chemical analysis. Four subpopulations of ﬁber type, referred to as type
I, II, I + IIa, and others (mainly IIb), were identiﬁed. Sectionswere stained
with the antibody speciﬁc to slow-type MHC, fast-type MHC, and the
BF32 antibody, which reacts with type I and IIa MHC (does not react
with IIb and IIx) [24]. Identiﬁcation of muscle ﬁbers revealed that
acetylcarnitine is enriched in type I ﬁbers (Fig. 3a). To semi-quantify the
apparent ﬁber-speciﬁc distribution of acetylcarnitine, a region of each
ﬁber typewas selected according to the images of immunohistochemical
analysis. Averaged spectra from each region were generated, and com-
pared among ﬁber types as previously shown [25–27]. Fig. 3b shows
the semi-quantitative comparison of carnitine and acetylcarnitine be-
tween different regions representative of different ﬁber types. Averaged
spectra from the type I ﬁber-enriched region was considered 100%, and
the values for other ﬁbers were expressed as a proportion of this. Al-
though there were no differences in carnitine contents between regions,
acetylcarnitine was signiﬁcantly greater in type I ﬁber-enriched areas
than in regions of type II and IIb ﬁbers (Fig. 3a, b).
We detected two other acylcarnitine species: octanoylcarnitine atm/z
288.4 and palmitoylcarnitine atm/z 400.6. Although the octanoylcarnitine
concentration was quite low, the palmitoylcarnitine concentration was
10–50% of the acetylcarnitine concentration and was distributed in
regions enriched with type I ﬁbers (Supplementary Fig. 1).
3.3. Energy charge in different ﬁber types
To evaluate the energy charge in different types of skeletal muscle
ﬁbers, we examined ions related to adenosine phosphates AMP, ADP,
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1702 Y. Furuichi et al. / Biochimica et Biophysica Acta 1837 (2014) 1699–1706and ATP [18]. As shown in Fig. 4, ATP, ADP, and AMP-related ions
were detected in negative-ion mode, and the energy charge was
calculated in each pixel by a formula proposed by Atkinson [22].
Low energy charge signal indicates decreased ATP to ADP ratio,
representing up-regulation of metabolic activities. We found that ener-
gy charge was lower in speciﬁc areas, suggesting the regiospeciﬁcity of
metabolic activity in rat gastrocnemius muscle. We then identiﬁed the
ﬁber type of this muscle section using immunohistochemistry and re-
vealed that the energy charge was lower in type I ﬁbers (Fig. 4).
The histogram shows that the energy charge was low in type I ﬁbers,
and high in type II ﬁbers, suggesting that metabolic activity was up-
regulated in type I ﬁbers. These data indicated that acetylcarnitine is
enriched in the slow-type regions with up-regulated metabolic
state.3.4. Effects of in situ muscle contraction on metabolism
Exercise has been shown to increase acetylcarnitine content in skel-
etal muscles for buffering excess carbon fuel [28]. Therefore, we exam-
ined the effect of muscle contraction on carnitine metabolism in
skeletal muscles. To conﬁrm the adequacy of our in situ contraction
model, we measured the muscle glycogen content by histochemical
and biochemical analyses. Fig. 5a shows theH&E stained images ofmus-
cle to identify the morphological differences between basal and
contracted tissues (contraction). There were no obvious differences in
myoﬁber conditions between the tissues. On the other hand, PAS stain-
ing, which detects glycogen in tissues, revealed that muscle glycogen
levels decreased after 30 min of muscle contraction (Fig. 5a). We also
measured glycogen content in homogenated muscles from contracted
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Fig. 3. Identiﬁcation of muscle ﬁber type in serial section of muscles (a) and quantiﬁcation of carnitine and acetylcarnitine in each ﬁber type (b). (a) Serial sections were stained with an-
tibodies against MHC I, II, or I + IIa. Four sub-populations of ﬁber type in the muscle section were determined by immunohistochemical images. It is assumed that type I (yellow), type II
(red), type I + IIa (blue), and type IIb (green) were abundant in each colored area. (b) Carnitine and acetylcarnitine intensity were quantiﬁed in each ﬁber type. Quantiﬁcation of the
molecules are expressed relative to the type I ﬁbers. Values are presented as mean ± SEM from 3 animals. *: p b 0.05 vs. type I.
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gen content was decreased in contracted muscle (Fig. 5b). However,
changes in carnitine and acylcarnitine levels following muscle contrac-
tion could not be detected in the enzymatic assay (Fig. 5c).
3.5. MALDI–IMS carnitine imaging after muscle contraction
It is essential to differentiate the kinetics of acetylcarnitine from
other species of acylcarnitine to understand the roles of carnitineAT
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Japan). The histogram was calculated examining each pixel.in the regulation of muscle metabolism. Therefore, we performed
MALDI–IMS and evaluated the changes in carnitine and acetylcarnitine
in the skeletal muscle caused by electrical pulse-evoked contraction.
Fig. 6 shows the MALDI–IMS results of carnitine and acetylcarnitine
in rested right leg (basal) and contracted left leg (contraction) after
5-min and30-minmuscle contractions. Itwas shown that acetylcarnitine
is enriched in the type I ﬁbers in both basal and contracted muscles after
5-min electrical stimulation (Fig. 6a), indicating that acetylcarnitine levels
did not change following a short-term contraction. On the other hand, we0 
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Fig. 5. Effect of muscle contraction on glycogen and carnitine contents in rat gastrocnemius muscles. (a) H&E- and PAS-stained images in basal and contracted muscles are shown. (b)
Glycogen content in basal and contractedmusclesmeasured by the biochemicalmethod. Values are presented asmean± SEM from6 animals. *: p b 0.05 vs. basalmuscles. (c) Comparison
of free carnitine and acylcarnitine contents in basal and contracted muscles. Values are presented as mean ± SEM from 6 animals. There were no signiﬁcant differences from muscle
contraction.
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30 min, while there was no change in contralateral basal muscles
(Fig. 6b). Indeed, the average spectra of acetylcarnitine in whole sections
of contracted muscles were signiﬁcantly greater (3.2-fold) than those of
basal muscles (Fig. 6b). Unlike acetylcarnitine, there was no change in
palmitoylcarnitine content after muscle contraction (Supplementary
Fig. 2). To examine the correlative distribution of acetylcarnitine accumu-
lation and muscle ﬁber type, we analyzed the serial sections through im-
munohistochemistry. Contrary to expectation, acetylcarnitine increases
were not ﬁber type-dependent. To conﬁrm whether the acetylcarnitineBa
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± SEM from 6 animals. *: p b 0.05 vs. basal muscle.accumulation was involved in muscle contractile activity, we compared
MALDI–IMS images with PAS staining. We found that acetylcarnitine-
enriched regions overlapped with glycogen-depleted regions, as indicat-
ed by black arrows (Fig. 6b).
4. Discussion
In the current study, we successfully evaluated acetylcarnitine
content and its distribution in rat gastrocnemius muscle using MALDI–
IMS. Since this imaging technique enabled retention of information of0 
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acetylcarnitine is abundant in type I ﬁbers in basal states. Moreover,
we showed that in situ muscle contraction increased acetylcarnitine
content, which was concomitant with depletion of muscle glycogen,
suggesting the tight coupling of acetylcarnitine accumulation and the
contractile activity of muscle ﬁbers. At the initial phase of muscle con-
traction (5-min contraction), acetylcarnitine content did not change,
but increased drastically after an additional 25 min of contraction
in rat skeletal muscle. Acetylcarnitine accumulation during muscle
contraction is presumed to be the excess production of acetyl-CoA
during glycolysis, which exceeds the tissue's demand. We observed
that the location of acetylcarnitine accumulation matched with the re-
gion of increased energy utilization due to muscle contraction, suggest-
ing that carnitine functions as an acceptor of excess acetyl-CoA and
contributes to metabolic ﬂexibility.
In previous reports, tissue acetylcarnitine level has primarily been
estimated by radioisotopic assays in which the amount of radiolabeled
metabolites reacting with CrAT in homogenized samples [10,11]. It
was recently demonstrated, however, that CrAT has speciﬁcity not
only to acetylcarnitine (C2) but also to propionylcarnitine (C3) or
butyrylcarnitine (C4) [12]. MALDI–IMS, the method we used in this
report, directly measures the acetylcarnitine molecule, showing the
precise acetylcarnitine amount without contamination by other
short-chain acylcarnitines. Indeed, we detected other acylcarnitines
(octanoylcarnitine and palmitoylcarnitine) and found that the
palmitoylcarnitine concentration was approximately 40% of the
acetylcarnitine level in type I ﬁbers. Therefore, it is likely that enzy-
matic assays overestimate the concentration of acetylcarnitine. To
conﬁrm the accuracy of the detected molecular peaks of the
acetylcarnitine ion, we performed tandemmass spectrometry and de-
tected the fragmented ions (Fig. 2b). The results matched the theoreti-
cal fragmented ions derived from acetylcarnitine, indicating the
detected signal is indeed the target molecule [23,29]. Additionally,
since extraction and puriﬁcation processes are not necessary for
MALDI–IMS, quantiﬁcation of the metabolite is more efﬁcient when
compared to classical methods. While there are various methods to
quantify carnitine species in biological tissues [11], MALDI–IMS is a sim-
ple and powerful tool for evaluating acetylcarnitine distribution.
Interestingly, it was revealed that acetylcarnitine was localized in a
speciﬁc region of rat gastrocnemius muscles in basal states; therefore,
we tried to separate the muscle ﬁber types and compare relative
amounts of acetylcarnitine between ﬁber types. Skeletal muscle ﬁbers
are generally categorized into three types, slow oxidative (type I), fast
oxidative glycolytic (type IIa), and fast glycolytic (type IIb) [16].We sep-
arated deep and surface portions of rat gastrocnemiusmuscles by visual
assessment and showed high acetylcarnitine concentration in the deep
portion. The deep portion of gastrocnemiusmuscle consists of oxidative
muscle ﬁbers (type I and type IIa). We also determined a type I ﬁber-
enriched area by immunohistochemical analysis and quantiﬁed the
acetylcarnitine content of the serial sections. Our data clearly showed
that acetylcarnitine is abundantly distributed in type I ﬁbers and at rel-
atively lower levels in type IIa ﬁbers. This is the ﬁrst report of visualiza-
tion of acetylcarnitine distribution and quantiﬁcation of its content in
different muscle ﬁber types using histological techniques.
To determine the relationship between acetylcarnitine distribution
and muscle metabolic activity, we evaluated the energy charge, an
index of metabolic activity [22]. It was demonstrated that the energy
chargewas lower in type Iﬁbers compared to type IIﬁbers, representing
that metabolic activity is higher in slow type ﬁbers. Since type I ﬁbers
have more mitochondria and a higher capacity for beta-oxidation [16],
they accumulate acetyl-CoA under resting conditions. Excess acetyl-
CoA is converted to acetylcarnitine, because acetyl-CoA acts as an
allosteric inhibitor of pyruvate dehydrogenase. Therefore, our ﬁnding
that acetylcarnitine distribution corresponds to metabolic activity
indicates the physiological signiﬁcance of carnitine buffering excess
acetyl-CoA in order to maintain appropriate levels of acetyl-CoA inmitochondria. Our data suggest that type I ﬁbers are highly adaptable
to utilizing lipids and carbohydrates as fuels and transitioning between
the two, a feature known as metabolic ﬂexibility [30].
In order to clarify the effect of muscle contraction on intramuscular
carnitinemetabolism,we performed electrostimulation on rat gastrocne-
mius muscles and compared the carnitine contents between basal and
contracting muscles. Although there were no changes in acetylcarnitine
content in muscles after 5-min contraction, acetylcarnitine levels in the
whole section increased about 3.2-fold in contracting muscles after
30min of contraction. In contrast to acetylcarnitine, there was no change
in palmitoylcarnitine content after muscle contraction, suggesting that
contraction-induced acetylcarnitine accumulation was not the result of
beta-oxidation but rather glucose oxidation. Moreover, we found that
acetylation of carnitine occurred locally, and were not ﬁber type-
dependent. Inconsistent with our data, a previous report indicated that
the accumulation of acetylcarnitine during voluntary cycling exercise
was higher in type I ﬁbers than in type II ﬁbers, based on biopsy of
human vastus lateralis muscles [31]. This discrepancy likely resulted
from the difference in the types of muscle contractions studied (i.e., vol-
untary exercise vs. forced contraction by electrical stimulation). In the
present study, the surface area of the gastrocnemius was preferentially
activated, as shown by the PAS stain (Fig. 6b). This indicates relatively
low activation of the muscle area containing the highest proportion of
type I ﬁbers.
In the present study, we demonstrated that contraction-induced
carnitine acetylation overlapped with glycogen depletion, suggesting
that carnitine acetylation depends on increased metabolic activity [32].
Importantly, we measured the change in acetylcarnitine concentration
of homogenizedmuscle samples by enzymaticmethods, but did not de-
tect a signiﬁcant change. This discrepancy is likely explained by contam-
ination by other acylcarnitine species in the enzymatic analysis.
Furthermore, contraction-induced carnitine kinetics is limited to the
speciﬁc region and is undetectablewhen analyzingwhole homogenized
muscles. Imaging techniques are beneﬁcial, not only for accuracy, but
also for detecting the local dynamics of metabolite distribution, which
could not be observed with general biochemical assays.
It is important to note the biological meaning of acetylcarnitine pro-
duction duringmuscle contraction. Asmentioned above, carnitine func-
tions as an acceptor for excess acetyl-CoA and relieves the inhibition of
glucose oxidation. In addition, it has been hypothesized that
acylcarnitine is exported frommuscle cells following the increase of in-
tracellular acylcarnitine concentration and acts as a biologically active
substrate [13]. Recently, it has been reported that acetylcarnitine is a
potentially beneﬁcial molecule in the treatment of various neurological
diseases such as Alzheimer's disease [33], implying the inter-organ
shuttle of carnitine systems. Interestingly, it has been reported that
plasma acetylcarnitine concentration increased during human exer-
cise [28], suggesting the possibility that accumulated acetylcarnitine
might be exported during muscle contraction. Further study is needed
to elucidate the export of acetylcarnitine during muscle contraction
and to determine its physiological signiﬁcance.
In conclusion, we showed the ﬁber-speciﬁc acetylcarnitine distribu-
tion of rat skeletal muscles using MALDI–IMS techniques. By identiﬁca-
tion of ﬁber type using immunohistochemical analysis in serial sections,
we revealed that acetylcarnitine is enriched in type I ﬁbers under basal
state. Acetylcarnitine is accumulated during contraction in skeletal
muscle, and this region of acetylcarnitine accumulation corresponds to
regions of glycogen depletion, suggesting carnitine acetylation occurs
with a high degree of metabolic demand induced by sustained muscle
contraction. Further investigations are required to elucidate the physio-
logical meaning of contraction-induced acetylcarnitine accumulation.
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